Evidence Hub

Fatal immune checkpoint inhibitor-related pneumonitis following postoperative nivolumab administration in a patient with unclassifiable interstitial pneumonia and resected lung squamous cell carcinoma: A case report

Eitetsu Koh, Yasuo Sekine, Kenzo Hiroshima

Respiratory Medicine Case Reports, 2025

Abstract

Background Immune checkpoint inhibitor-related pneumonitis (ICI-P) is a known but potentially fatal complication in patients with underlying interstitial lung disease (ILD). However, reports of ICI-P in the postoperative setting remain scarce. Case presentation We present a 67-year-old man with unclassifiable interstitial pneumonia who underwent right upper lobectomy for stage IB squamous cell carcinoma. Two cycles of adjuvant nivolumab were administered. Ten days after the second cycle, the patient developed fever and progressive dyspnea. Chest CT revealed diffuse ground-glass opacities and consolidation in both lungs. Despite initial improvement with high-dose corticosteroids, respiratory failure recurred and progressed rapidly. The patient died 21 days after onset. Pathological review of the resected lung confirmed fibrosis compatible with unclassifiable interstitial pneumonia and squamous cell carcinoma. No autopsy was performed. Conclusion This case highlights the potentially fatal risk of postoperative nivolumab therapy in patients with pre-existing ILD, even in the setting of unclassifiable interstitial pneumonia. Careful risk–benefit assessment is warranted when considering adjuvant immune checkpoint inhibitors in this population.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free